Prognostic role of PIK3CA mutations and their association with hormone receptor expression in breast cancer: a meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep06255.pdf
Reference49 articles.
1. Network, C. G. A. Comprehensive molecular portraits of human breast tumours. Nature 490, 61–70 (2012).
2. Boswell, K. A., Wang, X., Shah, M. V. & Aapro, M. S. Disease burden and treatment outcomes in second-line therapy of patients with estrogen receptor-positive (ER+) advanced breast cancer: a review of the literature. Breast 21, 701–706 (2012).
3. Glass, A. G., Lacey, J. V., Jr, Carreon, J. D. & Hoover, R. N. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography and estrogen receptor status. J Natl Cancer Inst 99, 1152–1161 (2007).
4. O'Brien, C. et al. Predictive biomarkers of sensitivity to the phosphatidylinositol 3′ kinase inhibitor GDC-0941 in breast cancer preclinical models. Clin Cancer Res 16, 3670–3683 (2010).
5. Mangone, F. R., Bobrovnitchaia, I. G., Salaorni, S., Manuli, E. & Nagai, M. A. PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients. Clinics (Sao Paulo) 67, 1285–1290 (2012).
Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer;Journal of Cancer Research and Clinical Oncology;2024-03-11
2. Mutational Landscape and In-Silico Analysis of TP53, PIK3CA, and PTEN in Patients with Breast Cancer from Khyber Pakhtunkhwa;ACS Omega;2023-11-02
3. Next-Generation Sequencing-Based Analysis of Clinical and Pathological Features of PIK3CA-Mutated Breast Cancer;Diagnostics;2023-09-08
4. Phosphoinositide 3-Kinase (PI3K) Inhibitors and Breast Cancer: An Overview of Current Achievements;Cancers;2023-02-23
5. Identifying Potential Molecules Downregulating APOBEC3B Mutation for Controlling Breast Cancer;Procedia Computer Science;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3